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A B S T R A C T
A simple and facile synthesis of 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-
2,4,6-trione derivatives was accomplished by the one-pot condensation of aromatic aldehydes,
1,3-indandione and 6-amino uracil under solvent-free conditions in the presence of the cata-
lyst, β-cyclodextrin-propyl sulfonic acid (β-CD-PSA).This method has the advantages of high
yield, clean reaction, simple methodology, and short reaction time. The catalyst could be
recycled and reused four times without significant loss of activity.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
The elimination of volatile and toxic organic solvents in chemi-
cal processes represents very powerful procedures for green
chemical technology from both the economic and synthetic
points of view (Kiyani and Ghiasi, 2015; Shaterian and Rigi, 2014;
Shirini et al., 2015). They have many advantages, such as
reduced pollution, lower cost, and simplicity in processing,
which are beneficial to the industry as well as to the
environment.
Pyrido[2,3-d]pyrimidines are annulated uracil which have
received considerable attention over the past years due to their
wide range of biological and pharmacological activities, which
include anticancer agents inhibiting dihydrofolate reducta-
ses or tyrosine kinases (Gangjee et al., 1996), cytotoxic (Moreno
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et al., 2012), antitumor (Broom et al., 1976; Grivsky et al., 1980),
anti-proliferative CDK2 inhibitor (Ibrahim and Ismail, 2011),
antihistaminic (Quintela et al., 1997), anti-inflammatory
(El-Gazzar and Hafez, 2009), antibacterial (Degraw et al., 1974;
Matsumoto and Minami, 1975), inhibitors of cyclin-dependent
kinases (Barvian et al., 2000), anti-allergic (Hermecz et al., 1984),
analgesic (Awoutters et al., 1986), calcium channel antago-
nists (Pastor et al., 1994), antihypertensive (Bennett et al., 1981)
and CNS depressant activity (Hasan et al., 1994). As a result,
the compounds of this class have attracted considerable in-
terests for research. Several methods have already been reported
for the synthesis of pyrido[2,3-d]pyrimidines (Abdolmohammadi
and Afsharpour, 2012; Baharfar and Azimi, 2011; Nemati and
Saeedirad, 2013; Nia et al., 2013; Quiroga et al., 1998; Rad and
Mokhtary, 2015; Sarmah et al., 2013; Wang et al., 2004, 2005;
Youssif et al., 1999; Ziarani et al., 2014).
The unique supramolecular property due to the hydropho-
bic cavity of CDs, enable the wide application of CDs in many
fields of science and technology (Harada et al., 1993, 2009).
β-Cyclodextrin based polyurethane has been reported as a
phase-transfer catalyst for the preparation of benzyl cya-
nides and azides in water (Kiasat and Nazari, 2012a), synthesis
of benzyl thiocyanates and acetates (Kiasat and Nazari,
2012b) and for the synthesis of 1,4-dihydropyridine and
polyhydroquinoline derivatives via the Hantzsch reaction (Kiasat
et al., 2014). β-Cyclodextrin-butane sulfonic acid has been re-
ported as an efficient and reusable catalyst for the multi-
component synthesis of 1-amidoalkyl-2-naphthols under
solvent-free conditions (Gong et al., 2015a) and synthesis of
1,8-dioxo-octahydroxanthenes (Gong et al., 2015b). Synthesis
of 3,4-dihydropyrimidones via Biginelli reaction (Gong et al.,
2015c) and 1,2,4,5-tetrasubstituted imidazoles (Ran et al., 2015)
have been achieved by using β-Cyclodextrin-propyl sulfonic acid.
The above mentioned observations led us to attempt the
synthesis of some indeno fused pyrido[2,3-d]pyrimidine de-
rivatives in the presence of β-cyclodextrin-propyl sulfonic acid
(β-CD-PSA). Furthermore, β-CD-PSA is inexpensive, biodegrad-
able, and can be reusable. In a continuation of our interest in
the synthesis of biologically active organic compounds bymulti-
component reactions (Ghashang et al., 2013, 2014a, 2014b,
2014c), we have developed an efficient synthesis of 5-aryl-5,11-
dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-
trione derivatives using β-CD-PSA as an efficient catalyst via
the cyclocondensation reaction of aromatic aldehydes, 1,3-
indandione and 6-amino uracil under solvent-free conditions
at 80 °C (Scheme 1).
2. Materials and methods
2.1. Chemicals and analysis
Chemicals were purchased from Merck, Fluka and Aldrich
Chemical Companies.Analytical thin-layer chromatography was
performed with E. Merck silica gel 60F glass plates. Visualiza-
tion of the developed chromatogramwas performed by UV light
(254 nm). Column chromatography was performed on silica gel
90, 200–300 mesh. Melting points were determined with
Shimadzu DS-50 thermal analyzer. The products were char-
acterized by comparison of their physical data with those of
known samples or by their spectral data. 1H NMR (500 MHz)
and 13C NMR (125 MHz) spectra were obtained using Bruker DRX-
500 Avance at ambient temperature, using TMS as internal
standard. FT-IR spectra were obtained as KBr discs on Shimadzu
spectrometer. Mass spectra were determined on a Varion –
Saturn 2000 GC/MS instrument. Elemental analysis was mea-
sured by means of Perkin Elmer 2400 CHN elemental analyzer
flowchart.
2.2. Preparation of β-CD-PSA
β-CD-PSA is prepared from β-CD and 1,3-propane sultone as
reported previously (Gong et al., 2015c) (Scheme 2).
2.3. General procedure for preparation of (4a-l)
A mixture of equimolar amounts of aryl aldehyde 1 (1 mmol),
1,3-indandione 2 (1 mmol) and 6-amino uracil 3 (1 mmol) was
heated at 80 °C under solvent-free condition in the presence
of β-CD-PSA (1 mol %).The progress of the reaction was moni-
tored by TLC (EtOAc/petroleum ether:1/9). Stirring at 80 °C was
continued until disappearance of the starting materials (moni-
tored by TLC). The reaction mixture was cooled and washed
with water. The solid obtained was recrystallized from MeOH
to furnish the desired pure product.
2.4. Spectral data for the synthesized compounds are
presented below (4a-l)
2.4.1. 5-Phenyl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido
[2,3-d]pyrimidine-2,4,6-trione (4a)
IR (KBr, cm−1): 3370, 3288, 3077, 2822, 1700, 1644, 1629, 1545, 1503,
1011, 852, 773; 1H NMR (500 MHz, DMSO-d6) δ: 4.77 (s, 1H, CH),
Scheme 1 – Synthesis of 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione.
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7.14–7.30 (m, 5H, Ar-H), 7.52–7.69 (m, 4H, Ar-H), 8.40 (s, br. 1H,
NH), 10.33 (s, br. 1H, NH), 10.88 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 38.9, 78.8, 103.5, 124.4, 125.2, 126.6, 127.5,
128.1, 128.7, 134.2, 135.3, 136.1, 144.2, 145.5, 152.0, 162.3, 163.1,
191.9 ppm; MS(ESI):m/z 344 (M + H)+; Anal. Calcd. for C20H13N3O3:
C, 69.96; H, 3.82; N, 12.24 %. Found: C, 69.88; H, 3.77; N,
12.21 %.
2.4.2. 5-(4-fluorophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4b)
IR (KBr, cm−1): 3355, 3277, 3060, 2817, 1702, 1652, 1633, 1547, 1517,
1022, 846, 769; 1H NMR (500 MHz, DMSO-d6) δ: 4.62 (s, 1H, CH),
7.16 (d, 2H, J = 8.2 Hz, Ar-H), 7.34 (d, 2H, J = 8.2 Hz, Ar-H), 7.49–
7.66 (m, 4H, Ar-H), 8.51 (s, br. 1H, NH), 10.29 (s, br. 1H, NH), 10.92
(s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 39.3, 79.5,
103.6, 124.7, 125.5, 126.2, 127.7, 128.3, 128.6, 134.6, 135.5, 136.7,
144.3, 145.7, 151.9, 162.4, 163.3, 191.8 ppm; MS(ESI): m/z 362
(M + H)+; Anal. Calcd. for C20H12FN3O3: C, 66.48; H, 3.35; N,
11.63 %. Found: C, 66.44; H, 3.32; N, 11.58 %.
2.4.3. 5-(4-methylphenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4c)
IR (KBr, cm−1): 3366, 3274, 3082, 2810, 1707, 1650, 1634, 1545, 1515,
1023, 847, 781; 1H NMR (500 MHz, DMSO-d6) δ: 2.26 (s, 3H, CH3),
4.75 (s, 1H, CH), 7.07 (d, 2H, J = 8.1 Hz,Ar-H), 7.29 (d, 2H, J = 8.1 Hz,
Ar-H), 7.55–7.67 (m, 4H, Ar-H), 8.47 (s, br. 1H, NH), 10.36 (s, br.
1H, NH), 10.80 (s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-
d6) δ: 17,5. 39.2, 79.7, 102.9, 123.8, 125.7, 126.4, 127.4, 128.0, 128.5,
134.3, 135.7, 136.3, 144.4, 145.9, 151.8, 161.7, 163.7, 192.3 ppm;
MS(ESI): m/z 358 (M + H)+; Anal. Calcd. for C21H15N3O3: C, 70.58;
H, 4.23; N, 11.76 %. Found: C, 70.53; H, 4.19; N, 11.72 %.
2.4.4. 5-(4-methoxyphenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4d)
IR (KBr, cm−1): 3330, 3280, 3085, 2808, 1711, 1646, 1629, 1544, 1509,
1014, 850, 770; 1H NMR (500 MHz, DMSO-d6) δ: 3.57 (s, 3H, OCH3),
4.66 (s, 1H, CH), 7.19 (d, 2H, J = 8.0 Hz,Ar-H), 7.37 (d, 2H, J = 8.0 Hz,
Ar-H), 7.48–7.63 (m, 4H, Ar-H), 8.53 (s, br. 1H, NH), 10.28 (s, br.
1H, NH), 10.94 (s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-
d6) δ: 38.8, 55.1, 79.3, 102.8, 123.7, 125.3, 126.7, 127.3, 128.2, 128.7,
134.5, 135.8, 136.5, 144.6, 145.8, 151.7, 161.9, 163.3, 192.4 ppm;
MS(ESI): m/z 374 (M + H)+; Anal. Calcd. for C21H15N3O3: C, 67.56;
H, 4.05; N, 11.25 %. Found: C, 67.55; H, 3.98; N, 11.19 %.
2.4.5. 5-(3-chlorophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4e)
IR (KBr, cm−1): 3341, 3270, 3075, 2804, 1714, 1643, 1625, 1533, 1505,
1017, 852, 766; 1H NMR (500 MHz, DMSO-d6) δ: 4.82 (s, 1H, CH),
7.20–7.30 (m, 4H, Ar-H), 7.52–7.67 (m, 4H, Ar-H), 8.56 (s, br. 1H,
NH), 10.17 (s, br. 1H, NH), 10.90 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 39.7, 79.8, 103.0, 123.6, 125.4, 126.8, 127.8,
128.3, 128.8, 134.7, 135.7, 136.6, 144.7, 145.6, 151.5, 161.8, 163.2,
192.6 ppm; MS(ESI): m/z 378.4 (M + H)+; Anal. Calcd. for
C20H12ClN3O3: C, 63.59; H, 3.20; N, 11.12 %. Found: C, 63.50; H,
3.16; N, 11.10 %.
2.4.6. 5-(3-nitrophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4f)
IR (KBr, cm−1): 3352, 3272, 3083, 2814, 1694, 1647, 1627, 1536, 1518,
1022, 847, 769; 1H NMR (500 MHz, DMSO-d6) δ: 4.74 (s, 1H, CH),
7.18–7.35 (m, 4H, Ar-H), 7.49–7.66 (m, 4H, Ar-H), 8.42 (s, br. 1H,
NH), 10.28 (s, br. 1H, NH), 10.78 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 39.0, 78.9, 103.3, 124.2, 125.3, 126.2, 127.2,
O
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Scheme 2 – Synthesis of β-CD-PSA from β-CD and 1,3-propane sultone.
342 b en i - s u e f un i v e r s i t y j o u rna l o f b a s i c and a p p l i e d s c i e n c e s 5 ( 2 0 1 6 ) 3 4 0 – 3 4 9
128.1, 128.6, 134.8, 135.6, 136.2, 144.8, 145.9, 152.2, 162.4, 163.6,
192.2 ppm; MS(ESI):m/z 389 (M + H)+; Anal. Calcd. for C20H12N4O5:
C, 61.86; H, 3.11; N, 14.43 %. Found: C, 61.81; H, 3.05; N,
14.39 %.
2.4.7. 5-(2-chlorophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4g)
IR (KBr, cm−1): 3371, 3285, 3082, 2820, 1698, 1651, 1631, 1543, 1519,
1024, 848, 773; 1H NMR (500 MHz, DMSO-d6) δ: 4.63 (s, 1H, CH),
7.07 -7.31 (m, 4H, Ar-H), 7.44–7.62 (m, 4H, Ar-H), 8.51 (s, br. 1H,
NH), 10.33 (s, br. 1H, NH), 10.84 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 38.9, 79.5, 102.7, 123.6, 125.5, 126.6, 127.3,
128.4, 128.8, 134.4, 135.6, 136.5, 144.6, 146.2, 151.9, 161.8, 163.3,
192.5 ppm; MS(ESI): m/z 378.4 (M + H)+; Anal. Calcd. for
C20H12ClN3O3: C, 63.59; H, 3.20; N, 11.12 %. Found: C, 63.48; H,
3.14; N, 11.07 %.
2.4.8. 5-(4-bromophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4h)
IR (KBr, cm−1): 3348, 3290, 3084, 2810, 1703, 1637, 1626, 1547, 1521,
1013, 842, 780; 1H NMR (500 MHz, DMSO-d6) δ: 4.70 (s, 1H, CH),
7.12 (d, 2H, J = 8.2 Hz, Ar-H), 7.32 (d, 2H, J = 8.2 Hz, Ar-H), 7.44–
7.60 (m, 4H, Ar-H), 8.45 (s, br. 1H, NH), 10.35 (s, br. 1H, NH), 10.89
(s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 39.3, 79.7,
102.8, 123.9, 125.9, 126.7, 127.5, 128.4, 128.5, 134.3, 135.5, 136.3,
144.5, 145.7, 151.6, 161.6, 163.7, 192.7 ppm; MS(ESI): m/z 422.5
(M + H)+; Anal. Calcd. for C20H12BrN3O3: C, 56.89; H, 2.89; N,
9.95 %. Found: C, 56.81; H, 2.87; N, 9.94 %.
2.4.9. 5-(4-nitrophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4i)
IR (KBr, cm−1): 3363, 3293, 3079, 2816, 1709, 1640, 1629, 1534, 1511,
1016, 838, 754; 1H NMR (500 MHz, DMSO-d6) δ: 4.81 (s, 1H, CH),
7.17 (d, 2H, J = 8.1 Hz, Ar-H), 7.38 (d, 2H, J = 8.1 Hz, Ar-H), 7.54–
7.71 (m, 4H, Ar-H), 8.40 (s, br. 1H, NH), 10.27 (s, br. 1H, NH), 10.93
(s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 39.3, 78.4,
103.4, 124.4, 125.3, 126.4, 127.3, 128.5, 128.9, 134.8, 135.6, 136.4,
144.7, 145.6, 152.4, 162.6, 163.7, 191.9 ppm; MS(ESI): m/z 389
(M + H)+; Anal. Calcd. for C20H12N4O5: C, 61.86; H, 3.11; N,
14.43 %. Found: C, 61.83; H, 3.07; N, 14.36 %.
2.4.10. 5-(4-chlorophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4j)
IR (KBr, cm−1): 3360, 3286, 3072, 2818, 1712, 1645, 1630, 1541, 1510,
1022, 850, 763; 1H NMR (500 MHz, DMSO-d6) δ: 4.73 (s, 1H, CH),
7.13 (d, 2H, J = 8.1 Hz, Ar-H), 7.29 (d, 2H, J = 8.1 Hz, Ar-H), 7.49–
7.69 (m, 4H, Ar-H), 8.46 (s, br. 1H, NH), 10.29 (s, br. 1H, NH), 10.86
(s, br. 1H, NH) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 38.7, 78.7,
103.5, 124.3, 125.5, 126.6, 127.7, 128.3, 128.7, 134.3, 135.3, 136.3,
144.3, 145.7, 152.4, 162.6, 163.4, 192.4 ppm; MS(ESI): m/z 378.4
(M + H)+; Anal. Calcd. for C20H12ClN3O3: C, 63.59; H, 3.20; N,
11.12 %. Found: C, 63.55; H, 3.18; N, 11.08 %.
2.4.11. 5-(3-bromophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4k)
IR (KBr, cm−1): 3372, 3290, 3081, 2807, 1715, 1647, 1632, 1543, 1504,
1023, 855, 762; 1H NMR (500 MHz, DMSO-d6) δ: 4.76 (s, 1H, CH),
7.10–7.27 (m, 4H, Ar-H), 7.46–7.61 (m, 4H, Ar-H), 8.47 (s, br. 1H,
NH), 10.22 (s, br. 1H, NH), 10.89 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 39.5, 79.5, 103.5, 123.3, 125.3, 126.4, 127.8,
128.3, 128.6, 134.6, 135.7, 136.6, 144.5, 145.4, 151.6, 161.5, 163.4,
190.9 ppm; MS(ESI): m/z 422.5 (M + H)+; Anal. Calcd. for
C20H12BrN3O3: C, 56.89; H, 2.89; N, 9.95 %. Found: C, 56.85; H, 2.85;
N, 9.90 %.
2.4.12. 5-(2-fluorophenyl)-5,11-dihydro-1H-indeno
[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione (4l)
IR (KBr, cm−1): 3357, 3283, 3080, 2805, 1692, 1654, 1635, 1540, 1503,
1025, 850, 767; 1H NMR (500 MHz, DMSO-d6) δ: 4.80 (s, 1H, CH),
7.15–7.33 (m, 4H, Ar-H), 7.40–7.63 (m, 4H, Ar-H), 8.45 (s, br. 1H,
NH), 10.32 (s, br. 1H, NH), 10.92 (s, br. 1H, NH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 39.5, 79.3, 103.7, 124.8, 125.5, 126.4, 127.6,
128.0, 128.8, 134.7, 135.6, 136.7, 144.7, 145.4, 152.0, 163.0, 164.1,
191.7 ppm; MS(ESI):m/z 362 (M + H)+; Anal. Calcd. for C20H12FN3O3:
Table 1 – Optimization of reaction conditions for the synthesis of 4ba.
Entry Catalyst Amount Solvent Temperature (°C) Time (min) Yield (%)b
1 β-CD-PSA 1 mol % CH3CN Reflux 60 54
2 β-CD-PSA 1 mol % H2O Reflux 60 74
3 β-CD-PSA 1 mol % MeOH Reflux 50 71
4 β-CD-PSA 1 mol % EtOH Reflux 40 70
5 β-CD-PSA 1 mol % CHCl3 Reflux 60 35
6 β-CD-PSA 1 mol % Solvent-free 80 30 95
7 β-CD-PSA 1 mol % Solvent-free rt 60 43
8 β-CD-PSA 1 mol % Solvent-free 50 45 60
9 β-CD-PSA 1 mol % Solvent-free 60 40 74
10 β-CD-PSA 1 mol % Solvent-free 70 35 82
11 β-CD-PSA 1 mol % Solvent-free 90 30 95
12 β-CD-PSA 0 mol % Solvent-free 80 60 0
13 β-CD-PSA 0.5 mol % Solvent-free 80 40 52
14 β-CD-PSA 1.5 mol % Solvent-free 80 30 95
15 β-CD 1 mol % Solvent-free 80 60 32
16 SPE-β-CD 1 mol % Solvent-free 80 90 54
17 CH3SO3H 1 mol % Solvent-free 80 75 35
18 p-TSA 1 mol % Solvent-free 80 90 38
a Reaction conditions: 4-fluorobenzaldehyde (1 mmol), 1,3-indandione (1 mmol) and 6-aminouracil (1 mmol); solvent 5 mL.
b Isolated yields.
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C, 66.48; H, 3.35; N, 11.63 %. Found: C, 66.40; H, 3.30; N,
11.61 %.
3. Results and discussion
In order to optimize the reaction conditions, we conducted the
condensation of 4-fluorobenzaldehyde (1) (1 mmol), 1,3-
indandione (2) (1 mmol) and 6-aminouracil (3) (1 mmol) as a
model reaction for the synthesis of 5-(4-fluorophenyl)-5,11-
dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-
trione in the presence of β-CD-PSA (1 mol%) in various solvents
and also under solvent-free condition (Table 1, entries 1–6).The
obtained results showed that the best result was obtained under
solvent-free condition (Table 1, entry 6).
To determine the effect of temperature on the model re-
action, the reaction was conducted in a range of different
temperatures, including room temperature, 50, 60, 70, 80 and
90 °C, in the presence of 1 mol % β-CD-PSA catalyst under
solvent-free conditions (Table 1, entries 6–11). As shown in
Table 1, when the reaction temperature was varied from room
temperature to 80 °C, the product yield gradually increased,with
the highest yield being obtained at 80 °C. Notably, higher tem-
perature (90 °C) makes no obvious difference in the yield of the
product (Table 1, entry 11).
To optimize the catalyst loading, the model reaction was
investigated in the range of 0–1.5 mol% of β-CD-PSA (Table 1,
entry 6 and entries 12–14). Also the results in Table 1 indicate
that a 1 mol% loading of β-CD-PSA was found to be sufficient
to promote the reaction and decreasing in the amounts of the
catalyst from 1 mol% led to an increase in reaction time and
decrease in yield. Notably, increasing of the catalyst did not
show any significant changes in yield and time of reaction
(Table 1, entry 14).
Scheme 3 – Mechanism for the synthesis of 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione.
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Table 2 – Synthesis of 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione derivatives in the
presence of β-CD-PSA (1 mol %)a.
Entry Aldehyde Product Time (min) Yield (%)b
1 40 92
2 30 95
3 50 87
4 50 86
5 30 93
6 30 92
7 45 87
(continued on next page)
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Table 2 – (continued)
Entry Aldehyde Product Time (min) Yield (%)b
8 30 92
9 30 93
10 30 93
11 30 91
12 45 89
a Reaction conditions: benzaldehyde (1 mmol), 1,3-indandione (1 mmol) and 6-aminouracil (1 mmol) under solvent-free conditions in the pres-
ence of β-CD-PSA (1 mol%).
b Isolated yields.
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Among the different catalysts tested, including
β-cyclodextrin (β-CD), sulfopropyl ether β-cyclodextrin (SPE-
β-CD), methane sulfonic acid (CH3SO3H), p-toluene sulfonic acid
(p-TSA), and β-CD-PSA, β-CD-PSA was found to be the most ef-
ficient in terms of the reaction time and yield of the product
(Table 1, entry 6, entries 15–18).
Having optimized the reaction parameters such as solvent,
temperature and catalyst loading, the application of this pro-
tocol to a variety of other aldehydes was investigated and the
results are summarized in Table 2. We have synthesized dif-
ferent derivatives of 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]
pyrido[2,3-d]pyrimidine-2,4,6-trione from a variety of sub-
strates from aldehydes, 1,3-indandione and 6-aminouracil in
the presence of 1 mol% of β-CD-PSA as catalyst. As in Table 2,
all the reactions consisting of those involving ortho-,meta-, and
para-substituted benzaldehydes proceeded smoothly and
afforded the corresponding 5-ahenyl-5,11-dihydro-1H-
indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione in moderate
to high yields. The results presented in Table 2 indicate that
the electron-donating group substituted benzaldehydes that
required prolonged reaction time to give the yields, while
electron-withdrawing group substituted the ones that gave evi-
dently increasing yields. However, ortho-substituted aromatic
aldehydes give relatively lower yields whether the substitu-
ent is an electron-donating group or an electron-withdrawing
group, probably because of steric hindrance.
A tentative mechanism for the formation of 5-aryl-5,11-
dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-
triones mediated by β-CD-PSA is outlined in Scheme 3.
Considering the protonic acid nature of β-CD-PSA, we propose
that the aldehyde is activated by β-CD-PSA and the activated
carbonyl (a) reacts with activated 1,3-indandione (b) to afford
intermediate (c). Then, 6-amino uracil attacks the intermedi-
ate (c) and affords intermediate (d) via Michael addition. The
intermediate (d) undergoes intramolecular cyclization with par-
ticipation of the amino function and one of the 1,3-indandione
carbonyl group to form (e). Then the removal of water from
(e) forms the 5-aryl-5,11-dihydro-1H-indeno[2′,1′:5,6]pyrido[2,3-
d]pyrimidine-2,4,6-trione as the targeted molecules. The high
reaction rate observed in the present method could be attrib-
uted to the fact that the acidic sites of β-CD-PSA activate
aldehydes efficiently and the hydrophobic central cavities of
β-CD units in β-CD-PSA act as a micro-vessel. In addition, the
hydrophilic exterior due to the outer –OH of the β-CD-PSA cavity
promoted the reaction via hydrogen bonding.
3.1. Reusability of β-CD-PSA
The recovery and reuse of catalysts are highly preferable for
a green process. Thus, the reusability of the catalyst was in-
vestigated by using 4-fluorobenzaldehyde, 1,3-indandione and
6-amino uracil as model substrates.The catalyst was easily re-
covered by filtration after the reaction and washed with acetone.
The filtrates were vacuumed and the resulting catalyst was
reused directly for the next run. The procedure was repeated,
and the results indicated that the catalyst could be recycled
four times with a slight loss of catalyst activity (Fig. 1). The
reason for the decreased yields may be that the catalyst was
partly lost when it was reused.
4. Conclusions
In summary, we have developed a convenient, efficient
method for the synthesis of 5-aryl-5,11-dihydro-1H-
indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine-2,4,6-trione via a
one-pot three component condensation of aromatic alde-
hydes, 1,3-indandione, 6-amino uracil using β-CD-PSA as a
catalyst under solvent-free conditions. The simplicity of the
procedure, eco-friendly and easy handling are the advan-
tages of these methods. In addition, low cost and reusability
of the catalyst make this methodology a valid contribution.
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